Another trial examining advanced LC patients primarily treated with surgery found that while high tumour tissue expression of CD4+ and CD8+ T cells initially appeared to improve survival, only higher serum levels of the cytokine IL-8 were a significant negative predictor of disease-specific survival in multivariate analysis [234]. The gene discussed is CD8A; the disease is neoplasm.